ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2010

Aug 27, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2010-08-25

Reporting Person: Cormack Scott Daniel (President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-25	Common Stock	M	1761	$3.889	Acquired	8067	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-25	Employee Stock Option (right to buy)	$3.889	M	1761	Disposed	2010-12-16	Common Stock (1761)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8092	Indirect
Common Stock	25680	Indirect

Footnotes

F1: Scott D. Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1.